Study guide

16.4 Evidence-Based Dentistry & Research Methods

MFDS Part 1 Membership of the Faculty of Dental Surgery

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

Current Exam Facts How to Use This Guide Eligibility, Booking & the MFDS Pathway

2 Basic Sciences, History Taking & Clinical Assessment

1.1 Head & Neck Anatomy and Underpinning Basic Sciences 1.2 History Taking, Communication & Clinical Examination 1.3 Special Tests, Investigations & Diagnostic Accuracy 1.4 Differential Diagnosis, Triage & When to Biopsy 1.5 Dental Anomalies & Developmental Conditions

3 Cariology, Operative Dentistry & Endodontics

2.1 Cariology & Caries Diagnosis 2.2 Caries Management & Prevention 2.3 Operative Dentistry & Cavity Preparation 2.4 Endodontics 2.5 Tooth Surface Loss & Tooth Discolouration

4 Periodontology & Prosthodontics

3.1 Periodontology 3.2 Fixed Prosthodontics 3.3 Removable Prosthodontics 3.4 Occlusion & Occlusal Assessment

5 Paediatric Dentistry, Orthodontics & Dental Trauma

4.1 Paediatric Dentistry 4.2 Orthodontics 4.3 Dental Trauma 4.4 Orthodontic Assessment, Indices & Referral 4.5 Impacted Teeth & Radiographic Localisation

6 Oral Surgery, Treatment Planning & Prevention

5.1 Oral Surgery & Extractions 5.2 Treatment Planning & Patient Management 5.3 Prevention & Health Promotion

7 Cardiovascular, Respiratory & Endocrine Disease

6.1 Cardiovascular Disease 6.2 Respiratory Disease 6.3 Endocrine Disease & Diabetes 6.4 Bleeding Disorders & Anticoagulation

8 Haematology, Infection & the Medically Compromised Patient

7.1 Haematology 7.2 Infectious Disease 7.3 The Medically Compromised Patient 7.4 Neurological & Gastrointestinal Disease

9 Medical Emergencies in Dental Practice

8.1 Medical Emergencies & Resuscitation 8.2 Anaphylaxis & Acute Allergy 8.3 Emergency Drugs & the Resuscitation Kit

10 Special Care Dentistry, Mental Health & Anxiety Management

9.1 Special Care Dentistry & Patients with Disability 9.2 Mental Health & Behavioural Science 9.3 Dental Anxiety & Behaviour Management

11 Oral Medicine — Mucosal Disease & Orofacial Pain

10.1 Oral Mucosal Disease & Lichen Planus 10.2 Vesiculobullous & Ulcerative Disorders 10.3 Candidiasis & Fungal Infections 10.4 Orofacial Pain & Neuropathic Disorders

12 Oral Pathology — Lesions, Cysts, Tumours & Salivary Glands

11.1 Premalignant Lesions & Oral Cancer 11.2 Odontogenic Cysts 11.3 Odontogenic & Non-Odontogenic Tumours 11.4 Salivary Gland Disease

13 Pharmacology — Local Anaesthesia, Analgesia & Sedation

12.1 Local Anaesthesia 12.2 Analgesics & NSAIDs 12.3 Conscious Sedation

14 Pharmacology — Antimicrobials, Prescribing & Drug Interactions

13.1 Antimicrobials & Antibiotic Stewardship 13.2 Prescribing & Drug Interactions

15 Dental Materials

14.1 Properties & Testing of Dental Materials 14.2 Amalgam & Metal Restorations 14.3 Composite Resin & Adhesive Dentistry 14.4 Impression Materials, Cements & Other Materials

16 Microbiology, Infection Control & Radiology

15.1 Oral Microbiology & Infection Control 15.2 Dental Radiology & Imaging 15.3 Radiation Protection

17 Law, Ethics, Professionalism & Evidence-Based Dentistry

16.1 Consent & Confidentiality 16.2 GDC Standards & Professionalism 16.3 Safeguarding & Duty of Candour 16.4 Evidence-Based Dentistry & Research Methods 16.5 Records, Information Governance & Regulation 16.6 Communication, Teamworking, Human Factors & Raising Concerns

18 Statistics, Dental Public Health, Critical Appraisal & Exam Strategy

17.1 Statistics & Critical Appraisal 17.2 Dental Public Health & Epidemiology 17.3 SBA Technique & Exam Strategy 17.4 Final Review & Key Points

16.4 Evidence-Based Dentistry & Research Methods

Key Takeaways Explain This Topic AI

Evidence-based dentistry integrates the best research evidence with clinical expertise and patient values; the hierarchy of evidence ranks systematic reviews/meta-analyses and randomised controlled trials above observational and case studies.

The PICO framework structures a clinical question: Population, Intervention, Comparison, Outcome — the basis for a focused literature search.

Study designs include RCTs (gold standard for therapy), cohort studies (risk/prognosis), case-control studies (rare diseases/exposures), cross-sectional (prevalence), and case series; each is suited to different questions and has characteristic biases.

Key validity concepts: randomisation and allocation concealment, blinding, intention-to-treat analysis, and the distinction between statistical significance (p-value) and clinical importance (effect size).

Critical appraisal tools (CASP, CONSORT, PRISMA, STROBE) provide checklists to assess the quality and applicability of evidence.

Last updated: August 2026

What Is Evidence-Based Dentistry?

Evidence-based dentistry (EBD) is the integration of:

The best research evidence (from well-designed studies).

Clinical expertise (the clinician's knowledge and judgement).

Patient values and circumstances (their preferences and situation).

EBD does not replace clinical judgement — it informs it. The dentist asks a focused question, finds the best evidence, appraises it, and applies it to the individual patient.

The Hierarchy of Evidence

Evidence is ranked by its susceptibility to bias. A common pyramid:

  • Level Study type Strength
  • 1 Systematic review / meta-analysis of RCTs Strongest
  • 2 Randomised controlled trial (RCT) Strong
  • 3 Cohort study (prospective) Moderate
  • 4 Case-control study Moderate-lower
  • 5 Cross-sectional study Lower
  • 6 Case series / case report Weakest
  • 7 Expert opinion / bench research Lowest

A systematic review with meta-analysis sits at the top because it synthesises multiple studies, reducing the bias of any single trial. The pyramid is a guide — a well-conducted cohort may answer some questions better than a flawed RCT, and the design must match the question.

The PICO Framework

A focused clinical question uses PICO :

P opulation/patient — who is the patient (age, condition, setting)?

I ntervention — what treatment/exposure is being considered?

C omparison — what is it being compared with (placebo, another treatment, no treatment)?

O utcome — what matters to the patient (cure, pain relief, adverse effects, survival)?

A fifth element, Timing and Study type (PICOTS), is sometimes added. PICO structures both the question and the literature search.

Example: In adults with chronic periodontitis (P), does full-mouth disinfection (I) compared with quadrant-wise scaling (C) reduce probing depth (O) at 6 months (T)?

Study Designs and Their Uses

  • Design Best for Key feature / bias
  • RCT Therapy/intervention efficacy Random allocation, blinding; gold standard but costly, ethical limits

Cohort (prospective) Prognosis, incidence, risk factors Follows exposed vs unexposed groups forward in time; recall bias avoided, but confounding

Case-control Rare diseases or exposures Compares cases vs matched controls retrospectively; recall and selection bias; suited to rare disease

  • Cross-sectional Prevalence Snapshot; cannot infer causation
  • Case series/report Rare presentations Descriptive only; no control group

Systematic review Synthesising evidence Pre-defined protocol, comprehensive search; risk of publication bias if not well done

  • Meta-analysis Combining data Quantitatively pools results; needs homogeneity (assessed by I² statistic)
  • Choosing the Right Design

Therapy question → RCT.

Harm/risk question → cohort or case-control.

Prognosis question → cohort.

Diagnosis question → cross-sectional with a reference standard.

Prevalence → cross-sectional.

  • Threats to Validity
  • Bias

Selection bias — systematic differences between groups (reduced by randomisation and allocation concealment).

Information/measurement bias — errors in measuring exposure or outcome (reduced by blinding and standardised tools).

Recall bias — differential recall between cases and controls.

Performance bias — differences in care apart from the intervention (reduced by blinding).

Attrition bias — differential loss to follow-up (assess by intention-to-treat analysis).

Publication bias — positive studies more likely published (assessed by funnel plot in reviews).

Confounding

A confounder is a third variable linked to both exposure and outcome that distorts the apparent association (e.g. smoking confounds the link between coffee and oral cancer). Controlled by randomisation (in RCTs), matching, stratification, and multivariable adjustment.

  • Statistical Significance and Clinical Importance
  • The p-value

The p-value is the probability of observing the data (or more extreme) if the null hypothesis were true . A conventional threshold p < 0.05 means a less than 5% probability of such a result by chance — but it does not measure effect size, clinical importance, or the probability that the null is true.

Confidence Intervals

A 95% confidence interval (CI) is the range within which the true effect is estimated to lie with 95% certainty. A CI that excludes the null value (0 for differences, 1 for ratios) indicates statistical significance; a narrow CI indicates precision; a wide CI indicates uncertainty.

Clinical vs Statistical Significance

A large study can find a statistically significant result of trivial clinical size. Always consider the effect size (e.g. mean difference, relative risk, number needed to treat) and the CI — not just the p-value.

Effect Size Measures

  • Measure Use
  • Relative risk (risk ratio) Ratio of risk in intervention vs control
  • Odds ratio Used in case-control studies
  • Number needed to treat (NNT) Patients to treat to prevent one outcome — intuitive and clinical
  • Absolute risk reduction (ARR) Difference in risk between groups

NNT = 1 / ARR. A smaller NNT is more effective.

Intention-to-Treat Analysis

In an RCT, intention-to-treat (ITT) analysis includes every participant in the group to which they were randomised, regardless of whether they completed or received the assigned treatment. ITT preserves the benefit of randomisation and reflects 'real-world' effectiveness. Per-protocol analysis (only those who completed the protocol) can introduce bias and overestimate efficacy.

Appraisal Tools

  • Tool Use
  • CASP (Critical Appraisal Skills Programme) Generic checklists for RCTs, cohort, case-control, qualitative
  • CONSORT Reporting RCTs
  • PRISMA Reporting systematic reviews and meta-analyses
  • STROBE Reporting observational studies (cohort, case-control, cross-sectional)
  • GRADE Grading the certainty of evidence (high/moderate/low/very low)
  • Levels of Certainty (GRADE)

GRADE classifies the certainty (quality) of a body of evidence as high, moderate, low, or very low — based on study design and factors that downgrade (risk of bias, inconsistency, indirectness, imprecision, publication bias) or upgrade (large effect, dose-response) the evidence. This moves beyond a single 'level' to a nuanced judgement of how much trust to place in a finding.

Applying Evidence

Find the best evidence → appraise it for validity and applicability → integrate with clinical judgement and the patient's values → monitor the outcome. The process is iterative: the question may need refining, and the evidence should be revisited as new studies appear.